Targeting druggable ion channels to harness cancer cell mechanobiology for therapy
Developmental Cell · 2026-06 · 61 (6) · 1169-1171
DOI: 10.1016/j.devcel.2026.05.008 ↗Kurz gefasst
Kommentar in der Zeitschrift Developmental Cell, 2026-06. Verfasst von Beatrice Angi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, University of Padua, Padua, Italy. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
In this issue of Developmental Cell, Gajda et al.1 identified the transcriptional partners and downstream targets of myocardin-related transcription factor A (MRTFA), a regulator of actin transcription and cancer cell stiffness. BK potassium channels emerged as pharmacological targets that stiffen cancer cells and enhance anti-tumor immune surveillance during metastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biology, University of Padua, Padua, Italy.
- Department of Biology, University of Padua, Padua, Italy. Electronic address: ildiko.szabo@unipd.it.
Zitieren
APA
Angi, B., & Szabo, I. (2026). Targeting druggable ion channels to harness cancer cell mechanobiology for therapy. Developmental Cell, 61(6), 1169-1171. https://doi.org/10.1016/j.devcel.2026.05.008
Vancouver
Angi B, Szabo I. Targeting druggable ion channels to harness cancer cell mechanobiology for therapy. Developmental Cell. 2026;61(6):1169-1171. doi:10.1016/j.devcel.2026.05.008
BibTeX
@article{Angi2026,
author = {Angi, Beatrice and Szabo, Ildiko},
title = {Targeting druggable ion channels to harness cancer cell mechanobiology for therapy},
journal = {Developmental Cell},
year = {2026},
volume = {61},
number = {6},
pages = {1169--1171},
doi = {10.1016/j.devcel.2026.05.008}
}
EUVIMED